These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3547805)

  • 21. Abrogation of cyclosporine/transfusion-induced enhancement of rabbit skin allografts by increased cyclosporine dosage.
    Smit WJ; Masendycz PJ; Dumble LJ; Francis DM; Clunie GJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1427-8. PubMed ID: 3274347
    [No Abstract]   [Full Text] [Related]  

  • 22. Pretransplant conditioning with donor-specific transfusions using heated blood and cyclosporine. Preservation of the transfusion effect in the absence of sensitization.
    Martinelli GP; Horowitz C; Chiang K; Racelis D; Schanzer H
    Transplantation; 1987 Jan; 43(1):140-5. PubMed ID: 3541314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged allograft survival in xenotransfused mice after graft and/or donor pretreatment with cyclosporine and/or concanavalin A.
    Sharma V; Toledo-Pereyra LH
    Transplantation; 1987 Apr; 43(4):587-9. PubMed ID: 3554648
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of the timing of antigen administration on synergistic immunosuppression with cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Jul; 40(1):108-10. PubMed ID: 3892789
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of a combined antigen-cyclosporine regimen in four transplantation models.
    Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626
    [No Abstract]   [Full Text] [Related]  

  • 26. [The synergistic effect of low-dose cyclosporine and fluocinolone acetonide on the survival of rat allogenic skin graft].
    Zhao XF
    Zhonghua Wai Ke Za Zhi; 1989 Aug; 27(8):495-7, 510. PubMed ID: 2620608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppression by cyclosporine in vivo need not block effector T-cell function in mice.
    Auchincloss H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):860. PubMed ID: 2650285
    [No Abstract]   [Full Text] [Related]  

  • 28. The fate of meshed allograft skin in burned patients using cyclosporin immunosuppression.
    Frame JD; Sanders R; Goodacre TE; Morgan BD
    Br J Plast Surg; 1989 Jan; 42(1):27-34. PubMed ID: 2645003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific unresponsiveness to allografts induced by cyclosporine is not antibody dependent.
    Hall BM; Jelbart ME; Dorsch SE
    Transplant Proc; 1985 Apr; 17(2):1650-2. PubMed ID: 3885499
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of a low-dose two-drug regimen of oral cyclosporine and delayed alternate day prednisone for immunosuppression in cadaver kidney transplantation.
    Belitsky P; MacDonald A; Cohen A; VGivner M; Sketris I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):78-81. PubMed ID: 3291314
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of combined cholera toxin and cyclosporine therapy on renal allograft survival in the rat.
    Tsugita M; Tsuru S; Takasaki K; Shinomiya N; Kobayashi S; Hanyu F
    Transplantation; 1989 Dec; 48(6):1064-5. PubMed ID: 2595766
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative study of skin graft survival rates in BALB/c mice treated with either cyclosporine A, cyclosporine G, or 1/1 combination of both.
    Masri MA
    Transplant Proc; 1992 Oct; 24(5):1661-2. PubMed ID: 1412788
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporine pharmacokinetics and pharmacodynamics after oral administration in the rat.
    Didlake RH; Kim EK; Grevel J; Jarolimek L; Kahan BD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):692-5. PubMed ID: 2966483
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term survival of skin allografts in rats treated with topical cyclosporine.
    Lai CS; Wesseler TA; Alexander JW; Babcock GF
    Transplantation; 1987 Jul; 44(1):83-7. PubMed ID: 3299925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abrogation of second-set rejection with cyclosporine.
    Schulak JA; Monson D; Shelby J; Corry RJ
    Transplantation; 1983 Sep; 36(3):289-93. PubMed ID: 6412405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretransplant transfusion and cyclosporine-induced enhancement of rabbit skin allografts. Donor-specific versus third-party blood.
    King HP; Clunie GJ; Dumble LJ
    Transplantation; 1984 Apr; 37(4):418-9. PubMed ID: 6369674
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhanced allograft survival in H-2 compatible cyclosporine-treated mice.
    Krob MJ; Shelby J
    J Trauma; 1988 Feb; 28(2):225-7. PubMed ID: 3279221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolongation of allograft survival in diabetic rats treated with cyclosporine by deoxyguanosine pretreatment of pancreatic islets of Langerhans.
    al-Abdullah IH; Kumar AM; al-Adnani MS; Abouna GM
    Transplantation; 1991 May; 51(5):967-71. PubMed ID: 2031280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac xenograft survival in baboons treated with cyclosporine in combination with conventional immunosuppression.
    Sadeghi AM; Robbins RC; Smith CR; Kurlansky RA; Michler RE; Reemtsma K; Rose EA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1149-52. PubMed ID: 3547854
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of Cyclosporin A on spontaneous autoimmune thyroiditis in obese strain (OS) chickens.
    Wick G; Boyd RL; Muller PU
    Adv Exp Med Biol; 1982; 149():711-7. PubMed ID: 6756079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.